Squarepoint Ops LLC Repligen Corp Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Repligen Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 92,605 shares of RGEN stock, worth $11.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
92,605
Previous 3,600 2472.36%
Holding current value
$11.6 Million
Previous $453,000 2942.16%
% of portfolio
0.02%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $4.15 Million - $5.79 Million
34,619 Added 59.7%
92,605 $13.8 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $5.21 Million - $7.94 Million
43,404 Added 297.65%
57,986 $7.31 Million
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $1.18 Million - $1.44 Million
6,890 Added 89.57%
14,582 $2.68 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $3.96 Million - $6.43 Million
-34,702 Reduced 81.86%
7,692 $1.38 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $4.36 Million - $5.68 Million
31,501 Added 289.19%
42,394 $6 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $1.68 Million - $2.16 Million
10,893 New
10,893 $1.83 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $176,301 - $281,574
1,099 New
1,099 $206,000
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $2.08 Million - $2.61 Million
-11,521 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $439,353 - $612,893
2,967 Added 34.69%
11,521 $2.21 Million
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $2.25 Million - $2.91 Million
-18,388 Reduced 68.25%
8,554 $1.26 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $197,149 - $293,603
2,090 Added 8.41%
26,942 $3.33 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $1.1 Million - $1.41 Million
12,902 Added 107.97%
24,852 $2.4 Million
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $373,187 - $470,426
5,054 Added 73.29%
11,950 $1.11 Million
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $528,578 - $658,636
6,896 New
6,896 $529,000
Q2 2019

Aug 14, 2019
SELL
$54.2 - $85.95 $252,030 - $399,667
-4,650 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $229,942 - $292,020
4,650 New
4,650 $275,000
Q2 2018

Aug 14, 2018
SELL
$35.26 - $47.04 $793,350 - $1.06 Million
-22,500 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$30.92 - $37.27 $292,379 - $352,425
9,456 Added 72.49%
22,500 $814,000
Q4 2017

Feb 14, 2018
SELL
$32.53 - $38.92 $169,871 - $203,240
-5,222 Reduced 28.59%
13,044 $473,000
Q3 2017

Nov 14, 2017
BUY
$36.98 - $46.06 $675,476 - $841,331
18,266
18,266 $700,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email